Skip to main content
. Author manuscript; available in PMC: 2024 Feb 9.
Published in final edited form as: N Engl J Med. 2020 Oct 1;383(14):1349–1357. doi: 10.1056/NEJMsa2013804

Table 2.

Adjusted Year-, Day-, and Visit-Level Outcomes for Male and Female PCPs.

Outcome Male PCPs Female PCPs Between-Group Difference*
Absolute (95% CI) Relative %
Per year
No. of physicians included in analysis 5284 3018
Allowed charges (U.S. $) 358,795.1 319,652.0 −39,143.2 (−53,523.0 to −24,763.4) −10.9
No. of visits 3058.2 2727.7 −330.5 (−406.6 to −254.3) −10.8
No. of days in clinic 203.3 197.9 −5.3 (−7.7 to −3.0) −2.6
Observed time spent in patient visits (min) 46,709.2 47,910.6 1201.3 (184.7 to 2218.0) 2.6
Per day
No. of physician-days included in the analysis 1,085,623 585,808
Allowed charges (U.S. $) 1,792.3 1,611.6 −180.7 (−246.8 to −114.7) −10.1
No. of visits 15.2 13.6 −1.6 (−1.9 to −1.3) −10.5
Observed time spent in patient visits (min) 231.5 239.2 7.7 (3.6 to 11.8) 3.3
Per visit
No. of visits included in the analysis 16,422,457 7,969,353
Allowed charges (U.S. $) 117.4 116.9 −0.5 (−4.3 to 3.2) −0.4
No. of diagnoses documented 3.4 3.7 0.2 (0.2 to 0.3) 5.9
No. of orders placed 2.6 3.1 0.5 (0.4 to 0.5) 19.2
Observed visit time (min) 15.3 17.6 2.4 (2.1 to 2.6) 15.7
Actual visit duration vs. scheduled duration (min) −0.9 0.8 1.8 (1.5 to 2.0) 188.9
*

The between-group difference is shown as the value among female PCPs, as compared with that among male PCPs.

For visits for which the observed visit time data were missing (i.e., time stamps were not recorded or did not meet quality standards), this value was derived by means of multiple imputation.

This value was calculated by subtracting the scheduled visit duration from the observed visit time. Data are provided for the 83.8% of visits for which information about the scheduled visit duration was available. (Details regarding this category are provided in the Supplementary Appendix.)